Atlas Trials

Corvus Pharmaceuticals, Inc.

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Corvus Pharmaceuticals, Inc.

RecordFirmDate
Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD (NCT07441395)Corvus Pharmaceuticals, Inc.2026-02-01
Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe AD (NCT06345404)Corvus Pharmaceuticals, Inc.2024-04-16
CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients (NCT04734873)Corvus Pharmaceuticals, Inc.2021-02-25
Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients (NCT04464395)Corvus Pharmaceuticals, Inc.2020-07-01
Study of Ciforadenant in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma (NCT04280328)Corvus Pharmaceuticals, Inc.2020-02-20
A Dose Escalation Study Evaluating CPI-818 in Relapsed/Refractory T-Cell Lymphoma (NCT03952078)Corvus Pharmaceuticals, Inc.2019-05-03
CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers (NCT03454451)Corvus Pharmaceuticals, Inc.2018-04-25

Track Corvus Pharmaceuticals, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.